A GATA factor mediates cell type-restricted induction of HLA-E gene transcription by gamma interferon

Molecular and Cellular Biology

Volumn 24, Issue 14, 2004, Pages 6194-6204

  Barrett, David M ^a,c   Gustafson, Karen S ^b   Wang, Jing ^a   Wang, Shou Zhen ^a   Ginder, Gordon D ^a,b,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A PROTEIN; GAMMA INTERFERON; HLA E ANTIGEN; INTERFERON; PROTEIN P300; PROTEIN STAT 1ALPHA; STAT1 PROTEIN; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL TYPE; CHROMATIN; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA RESPONSIVE ELEMENT; ENHANCER REGION; GAMMA INTERFERON RESPONSIVE ELEMENT; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CELL LINE; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENES, REPORTER; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ADENOVIRIDAE;

EID: 3042836707     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.14.6194-6204.2004     Document Type: Article

References (48)

1. Adams, E. J., and P. Parham. 2001. Species-specific evolution of MHC class I genes in the higher primates. Immunol. Rev. 183:41-64.
2. Aittomaki, S., J. Yang, E. W. Scott, M. C. Simon, and O. Silvennoimen. 2002. Distinct functions for signal transducer and activator of transcription 1 and PU. 1 in transcriptional activation of Fcγ receptor 1 promoter. Blood 100: 1078-1080.
3. Aldrich, C. J., A. DeCloux, A. S. Woods, R. J. Cotter, M. J. Soloski, and J. Forman. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class 1b antigen. Cell 79:649-658.
4. Bach, E. A., M. Aguet, and R. D. Schrieber. 1997. The IFN-gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591.
5. Barrett, D. 2003. Ph.D. thesis. Virginia Commonwealth University, Richmond.
6. Bloebel, G. A., T. Nakajima, R. Eckner, M. Montminy, and S. H. Orkin. 1998. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl. Acad. Sci. USA 95:2061-2066.
7. Bloebel, G. A., M. C. Simon, and S. H. Orkin. 1995. Rescue of GATA-1-deficient embryonic stem cells by heterologous GATA-binding proteins. Mol. Cell. Biol. 15:626-633.
8. Braud, V. M., D. S. J. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to natural killer cell receptors. Nature 391:795-799.
9. Braud, V. M., D. S. J. Allan, D. Wilson, and A. J. McMichael. 1997. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1-10.
10. Braud, V. M., E. Y. Jones, and A. J. McMichael. 1997. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27:1164-1169.
11. Briegel, K., K. C. Lim, C. Plank, H. Beug, J. D. Engel, and M. Zenke. 1993. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev. 7:1097-1109.
12. Chen, E., R. W. Karr, J. P. Frost, T. A. Gonwa, and G. D. Ginder. 1986. Gamma interferon and 5-azacytidine cause transcriptional elevation of class I major histocompatibility complex gene expression in K562 leukemia cells in the absence of differentiation. Mol. Cell. Biol. 6:1698-1705.
13. Cooper, M. J., M. Lippa, J. M. Payne, G. Hatzivassiliou, E. Reifenberg, B. Fayazi, J. Perales, L. J. Morrison, D. Templeton, R. L. Piekarz, and J. Tan. 1997. Safety-modified episomal vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 94:6450-6455.
14. Deconinck, A. E., P. E. Mead, S. G. Tevosian, J. D. Crispino, S. G. Katz, L. I. Zon, and S. H. Orkin. 2000. FOG acts as a repressor of red blood cell development in Xenopus. Development 127:2031-2040.
15. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
16. Evans, T., and G. Felsenfeld. 1989. The erythroid-specific transcription factor Eryfl: a new finger protein. Cell 58:877-885.
17. Friedman, R. L., and G. R. Stark. 1985. α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314:637-639.
18. Fujita, T., Y. Kimura, M. Miyamoto, E. L. Barsoumian, and T. Taniguchi. 1989. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 337:270-272.
19. George, K., M. Leonard, M. Roth, K. Liew, D. Koussis, F. Grosveld, and J. D. Engel. 1994. Embryonic expression and cloning of the murine GATA-3 gene. Development 120:2673-2686.
20. Goh, K. C., S. J. Haque, and B. R. Williams. 1999. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18:5601-5608.
21. Gustafson, K. S., and G. D. Ginder. 1996. Interferon-gamma induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STAT1-alpha to a distinct interferon-gamma-responsive element. J. Biol. Chem. 271:20035-20046.
22. Hakem, R., P. LeBouteiller, A. Jezo-Brem, K. Harper, D. Campese, and F. Lemonnier. 1991. Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences. J. Immunol. 147:2384-2390.
23. phox gene. J. Biol. Chem. 277:9103-9111.
24. Kurepa, Z., C. A. Hasemann, and J. Forman. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188:973-978.
25. Lee, N., M. Llano, M. Carretero, A. Ishitiani, F. Navarro, M. Lopez-Botet, and D. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95:5199-5204.
26. Levy, D. E., D. S. Kessler, R. Pine, and J. E. Darnell, Jr. 1989. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha- stimulated transcription, reconstituted in vitro. Genes Dev. 3:1362-1371.
27. Lew, D. J., T. Decker, and J. E. Darnell, Jr. 1989. Alpha interferon and gamma interferon stimulate transcription of a single gene through different signal transduction pathways. Mol. Cell. Biol. 9:5404-5411.
28. Malmberg, K., V. Levitsky, H. Norell, C. de Matos, M. Carlsten, K. Schedvins, A. Moretta, H. Rabbani, A. Moretta, K. Soderstrom, J. Levitskaya, and R. Kiessling. 2002. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J. Clin. Investig. 110:1515-1523.
29. Marin, R., F. Ruiz-Cabello, S. Pedrinaci, R. Mendez, P. Jimenez, D. Geraghty, and F. Garrido. 2003. Analysis of HLA-E expression in human tumors. Immunogenetics 54:767-775.
30. Molkentin, J. D. 2000. The zinc finger-containing transcription factors GATA-4, -5, and -6: ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 275:38949-38952.
31. O'Callaghan, C. A., and J. I. Bell. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163: 129-138.
32. Petersson, E., R. Holmdahl, G. W. Butcher, and G. Hedlund. 1999. Activation and selection of NK cells via recognition of an allogeneic, non-classical MHC class I molecule, RT1-E. Eur. J. Immunol. 29:3663-3673.
33. Shuai, K., C. Schindler, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-1812.
34. Speiser, D. E., M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J. C. Cerottini, V. Cerundolo, and P. Romero. 1999. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytotoxic T-lymphocytes. J. Exp. Med. 190:775-782.
35. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schrieber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
36. Svensson, E. C., G. S. Huggins, F. B. Dardik, C. E. Polk, and J. M. Leiden. 2000. A functionally conserved N-terminal domain of the friend of GATA-2 (FOG-2) protein represses GATA4-dependent transcription. J. Biol. Chem. 275:20762-20769.
37. Tsai, S. F., D. I. Martin, L. I. Zon, A. D. D'Andrea, G. G. Wong, and S. H. Orkin. 1989. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339:446-451.
38. Vegh, Z., P. Wang, F. Vanky, and E. Klein. 1993. Increased expression of MHC class I molecules on human cells after short time IFN-gamma treatment. Mol. Immunol. 30:849-854.
39. Wang, H., Y. Rikitake, M. Carter, Y. Yaciuk, S. Abraham, B. Zerler, and E. Moran. 1993. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:476-488.
40. Waring, J. F., J. E. Radford, L. J. Burns, and G. D. Ginder. 1995. The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression. J. Biol. Chem. 270:12276-12285.
41. Watamoto, K., M. Towatari, Y. Ozawa, Y. Miyata, M. Okamoto, A. Abe, T. Naoe, and H. Saito. 2003. Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation. Oncogene 22:9176-9184.
42. Wei, X., and H. Orr. 1990. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum. Immunol. 29:131-142.
43. Weiss, M. J., G. Keller, and S. H. Orkin. 1994. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev. 8:1184-1197.
44. Weiss, M. J., and S. H. Orkin. 1995. GATA transcription factors: key regulators of hematopoiesis. Exp. Hematol. 23:99-107.
45. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
46. Williams, T. M. 2001. Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. J. Mol. Diagn. 3:98-104.
47. Wingender, E., X. Chen, R. Hehl, H. Karas, I. Leibich, V. Matys, T. Meinhardt, M. Pruss, I. Reuter, and F. Schacherer. 2000. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 28:316-319.
48. Zhang, J., U. Vinkmeier, W. Gu, D. Chakravarti, C. Horvath, and J. E. Darnell, Jr. 1996. Two contact regions between Stat1 and CBP/p300 in interferon-gamma signaling. Proc. Natl. Acad. Sci. USA 93:15092-15096.